Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Moleculin Biotech ( (MBRX) ) has issued an update.
Moleculin Biotech, Inc. announced the use of a corporate presentation as part of its communication strategy, which is now available on their website. This presentation is being shared for informational purposes and will not be filed under the Securities Exchange Act, which may impact how stakeholders and investors perceive the company’s communications.
More about Moleculin Biotech
YTD Price Performance: 1.13%
Average Trading Volume: 51,114
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.71M
See more data about MBRX stock on TipRanks’ Stock Analysis page.
Trending Articles
- Apple Settles $95M Class Action Suit and Clears Siri’s Privacy Norms
- Biden Plans One Last Chip Export Curb on Nvidia Before Leaving Office
- 3 Penny Stocks to Watch Now, 1/9/25
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
